MetLife Investment Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Sell |
205,505
-6,062
| -3% | -$540K | 0.09% | 203 |
|
|
2025
Q4 | $16.7M | Sell |
211,567
-6,933
| -3% | -$544K | 0.08% | 220 |
|
|
2025
Q3 | $17.5M | Sell |
218,500
-5,232
| -2% | -$446K | 0.08% | 207 |
|
|
2025
Q2 | $20.3M | Sell |
223,732
-6,530
| -3% | -$596K | 0.12% | 146 |
|
|
2025
Q1 | $21.6M | Sell |
230,262
-5,614
| -2% | -$503K | 0.12% | 137 |
|
|
2024
Q4 | $21.4M | Buy |
235,876
+3,134
| +1% | +$299K | 0.12% | 132 |
|
|
2024
Q3 | $24.2M | Sell |
232,742
-6,686
| -3% | -$681K | 0.14% | 115 |
|
|
2024
Q2 | $23.2M | Buy |
239,428
+46,691
| +24% | +$4.31M | 0.14% | 117 |
|
|
2024
Q1 | $17.4M | Sell |
192,737
-7,091
| -4% | -$601K | 0.12% | 137 |
|
|
2023
Q4 | $15.9M | Sell |
199,828
-4,533
| -2% | -$341K | 0.11% | 137 |
|
|
2023
Q3 | $14.5M | Sell |
204,361
-6,024
| -3% | -$450K | 0.11% | 142 |
|
|
2023
Q2 | $16.2M | Sell |
210,385
-25,339
| -11% | -$1.96M | 0.12% | 136 |
|
|
2023
Q1 | $17.7M | Sell |
235,724
-2,535
| -1% | -$189K | 0.13% | 122 |
|
|
2022
Q4 | $18.8M | Sell |
238,259
-4,162
| -2% | -$312K | 0.14% | 115 |
|
|
2022
Q3 | $17M | Sell |
242,421
-3,973
| -2% | -$312K | 0.14% | 116 |
|
|
2022
Q2 | $19.7M | Sell |
246,394
-2,595
| -1% | -$203K | 0.15% | 110 |
|
|
2022
Q1 | $18.9M | Buy |
248,989
+62,769
| +34% | +$4.97M | 0.12% | 133 |
|
|
2021
Q4 | $15.9M | Sell |
186,220
-4,296
| -2% | -$335K | 0.13% | 127 |
|
|
2021
Q3 | $14.4M | Sell |
190,516
-5,618
| -3% | -$446K | 0.13% | 131 |
|
|
2021
Q2 | $16M | Sell |
196,134
-6,077
| -3% | -$497K | 0.14% | 125 |
|
|
2021
Q1 | $15.9M | Sell |
202,211
-5,957
| -3% | -$467K | 0.15% | 123 |
|
|
2020
Q4 | $17.8M | Sell |
208,168
-9,220
| -4% | -$762K | 0.17% | 105 |
|
|
2020
Q3 | $16.8M | Sell |
217,388
-6,626
| -3% | -$505K | 0.18% | 99 |
|
|
2020
Q2 | $16.4M | Buy |
224,014
+3,100
| +1% | +$220K | 0.19% | 99 |
|
|
2020
Q1 | $14.7M | Sell |
220,914
-6,759
| -3% | -$477K | 0.2% | 100 |
|
|
2019
Q4 | $15.7M | Sell |
227,673
-5,821
| -2% | -$397K | 0.16% | 117 |
|
|
2019
Q3 | $17.2M | Sell |
233,494
-3,146
| -1% | -$228K | 0.19% | 99 |
|
|
2019
Q2 | $17M | Sell |
236,640
-8,288
| -3% | -$588K | 0.18% | 102 |
|
|
2019
Q1 | $16.8M | Sell |
244,928
-3,088
| -1% | -$199K | 0.18% | 104 |
|
|
2018
Q4 | $14.8M | Sell |
248,016
-4,392
| -2% | -$275K | 0.18% | 101 |
|
|
2018
Q3 | $16.9M | Sell |
252,408
-4,383
| -2% | -$292K | 0.17% | 108 |
|
|
2018
Q2 | $16.6M | Sell |
256,791
-6,629
| -3% | -$434K | 0.2% | 90 |
|
|
2018
Q1 | $18.9M | Sell |
263,420
-8,273
| -3% | -$595K | 0.22% | 81 |
|
|
2017
Q4 | $20.5M | Buy |
+271,693
| New | +$19.8M | 0.23% | 78 |
|
Other funds holding CL
VCM
DAM
VPM
MetLife Investment Management's CL Position: Q1 2026 in Review
MetLife Investment Management reduced its Colgate-Palmolive (CL) stake by 2.9% in Q1 2026, selling an estimated $540K and leaving 205,505 shares worth $17.5M. The position accounts for 0.09% of the portfolio, ranked #203.
MetLife Investment Management first reported a position in CL in Q4 2017 and has held it in 34 quarters since. The position peaked at $24.2M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- MetLife Investment Management held 205,505 shares of Colgate-Palmolive worth $17.5M as of Q1 2026.
- MetLife Investment Management sold 6,062 Colgate-Palmolive shares in Q1 2026, an estimated $540K.
- Colgate-Palmolive made up 0.09% of MetLife Investment Management's portfolio in Q1 2026, its #203 holding.
- MetLife Investment Management first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Colgate-Palmolive position peaked at $24.2M in Q3 2024.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.